Calidi Biotherapeutics (CLDI) Shares Outstanding (Diluted Average) (2021 - 2025)

Calidi Biotherapeutics has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $4302.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 544.98% year-over-year to $4302.0; the trailing twelve-month figure through Dec 2025 stood at $4302.0 (up 544.98% YoY), and the FY2025 full-year result was $4302.0, up 544.98% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $4302.0, up from $3362.0 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $8.9 million in Q4 2021, with the low at $444.0 in Q2 2024.
• Average Shares Outstanding (Diluted Average) over 5 years is $2.9 million, with a median of $878000.0 recorded in 2023.
• Year-over-year, Shares Outstanding (Diluted Average) plunged 99.96% in 2024 and soared 661.91% in 2025.
• Tracing CLDI's Shares Outstanding (Diluted Average) over 5 years: stood at $8.9 million in 2021, then retreated by 4.33% to $8.5 million in 2022, then slumped by 80.18% to $1.7 million in 2023, then sank by 99.96% to $667.0 in 2024, then surged by 544.98% to $4302.0 in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $4302.0 (Q4 2025), $3362.0 (Q3 2025), and $2877.0 (Q2 2025), per Business Quant data.

Peer Comparison